CeriBell (CBLL) News Today $26.31 +1.08 (+4.28%) (As of 11/22/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Ceribell’s Strategic Growth Potential: A Buy Rating Backed by Strong Financials and Competitive EdgeNovember 23 at 2:40 AM | markets.businessinsider.comCeriBell: Healthcare Technology Stock With A Promising Growth OutlookNovember 20 at 9:10 AM | seekingalpha.comCeribell Appoints Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of MarketingNovember 19, 2024 | markets.businessinsider.comCeribell appoints Rodenbush as CPO, Price as SVP of MarketingNovember 19, 2024 | markets.businessinsider.comFY2024 EPS Estimates for CeriBell Decreased by William BlairCeriBell (NASDAQ:CBLL - Free Report) - Analysts at William Blair decreased their FY2024 earnings estimates for CeriBell in a research note issued to investors on Wednesday, November 13th. William Blair analyst M. Andrew now forecasts that the company will earn ($3.07) per share for the year, downNovember 18, 2024 | marketbeat.comCeriBell's (NASDAQ:CBLL) Quiet Period Will End on November 20thNovember 17, 2024 | americanbankingnews.comWilliam Blair Estimates CeriBell's Q1 Earnings (NASDAQ:CBLL)CeriBell (NASDAQ:CBLL - Free Report) - Equities research analysts at William Blair issued their Q1 2026 earnings per share (EPS) estimates for shares of CeriBell in a research note issued on Wednesday, November 13th. William Blair analyst M. Andrew expects that the company will post earnings of (November 15, 2024 | marketbeat.comCanaccord Genuity Group Forecasts Strong Price Appreciation for CeriBell (NASDAQ:CBLL) StockNovember 15, 2024 | americanbankingnews.comCeribell Inc.’s Strong Financial Performance and Strategic Growth Initiatives Drive Buy RecommendationNovember 14, 2024 | markets.businessinsider.comCeribell price target raised to $31 from $30 at CanaccordNovember 14, 2024 | markets.businessinsider.comCeribell Reports Third Quarter 2024 Financial ResultsNovember 14, 2024 | markets.businessinsider.comCeribell, Inc. Reports Strong Q3 2024 GrowthNovember 14, 2024 | markets.businessinsider.comCanaccord Genuity Group Issues Positive Forecast for CeriBell (NASDAQ:CBLL) Stock PriceCanaccord Genuity Group increased their target price on shares of CeriBell from $30.00 to $31.00 and gave the company a "buy" rating in a research note on Wednesday.November 13, 2024 | marketbeat.comCeriBell's Quiet Period To End on November 20th (NASDAQ:CBLL)CeriBell's (NASDAQ:CBLL - Get Free Report) quiet period will end on Wednesday, November 20th. CeriBell had issued 10,606,060 shares in its initial public offering on October 11th. The total size of the offering was $180,303,020 based on an initial share price of $17.00. During CeriBell's quiet period, insiders and underwriters that worked on the IPO are restricted from issuing any research reports or earnings estimates for the company because of SEC regulations. Following the expiration of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.November 13, 2024 | marketbeat.comCeribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNovember 7, 2024 | globenewswire.comCeriBell: An Interesting EEG Play Going PublicOctober 21, 2024 | seekingalpha.com Get CeriBell News Delivered to You Automatically Sign up to receive the latest news and ratings for CBLL and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump Wins… But Elon Says Get Ready to Brace (Ad)Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back… Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov CBLL Media Mentions By Week CBLL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CBLL News Sentiment▼0.600.49▲Average Medical News Sentiment CBLL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CBLL Articles This Week▼105▲CBLL Articles Average Week Get CeriBell News Delivered to You Automatically Sign up to receive the latest news and ratings for CBLL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Inari Medical News LivaNova News TransMedics Group News Enovis News Soleno Therapeutics News Warby Parker News iRhythm Technologies News CONMED News Tandem Diabetes Care News NovoCure News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CBLL) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CeriBell Please log in to your account or sign up in order to add this asset to your watchlist. Share CeriBell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
